Mobile

Open label Extension Study Following Double-blind, Randomized, Placebo-controlled, Multicentre Study to Assess Efficacy and Safety of Adjunctive Zonisamide in Myoclonic Seizures associated with Idiopa...

Mise à jour : Il y a 4 ans
Référence : EUCTR2007-006696-36

Open label Extension Study Following Double-blind, Randomized, Placebo-controlled, Multicentre Study to Assess Efficacy and Safety of Adjunctive Zonisamide in Myoclonic Seizures associated with Idiopathic Generalized Epilepsy

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To assess the long-term safety of zonisamide in subjects with myoclonic seizures.

Critère d'inclusion

  • Myoclonic seizures in idiopathic generalised epilepsy (IGE)

Liens